ArticleFrontiers in endocrinology2026
Sex differences in iron stores and associations of body iron with cardiovascular risk factors in the middle-aged general population.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Men and women exhibit clear differences in both atherosclerotic cardiovascular disease and iron metabolism, although specific cardiovascular risk factors associated with body iron stores remain unclear. This study investigates if there are sex-specific differences in ferritin or total body iron (TBI) and their associations with cardiovascular risk factors and the metabolic syndrome. Methods: A total of 1,272 participants (640 men, 632 women) were randomly selected from the Swedish CArdiopulmonary Bioimage Study (SCAPIS). Iron-related biomarkers including ferritin, hemoglobin, soluble transferrin receptor, sTfR/log ferritin index, and TBI were analyzed in relation to conventional cardiovascular risk factors. Results: Men had higher iron stores than both premenopausal and postmenopausal women. They also demonstrated a more adverse cardiovascular risk profile with higher body mass index (BMI), a higher prevalence of hypertension, hyperlipidemia, diabetes, and prior myocardial infarction and a more atherogenic lipid profile than women. The prevalence of hyperferritinemia was 21.6% in men versus 12.0% in women (p < 0.01), whereas that of metabolic syndrome was 34.5% in men versus 24.6% in women (p < 0.01). In both sexes, BMI, alcohol consumption, LDL cholesterol, and triglycerides were associated with ferritin levels. Unlike men, women showed a significant association between age or hypertension and ferritin levels. Furthermore, ferritin, TBI, and hyperferritinemia were associated with metabolic syndrome in both sexes. Conclusions: This study highlights sex-specific differences in body iron stores, prevalence of cardiovascular disease comorbidity, and cardiovascular metabolic status. Hyperferritinemia or TBI was associated with metabolic syndrome in both sexes. In women, but not in men, age or hypertension was associated with ferritin levels. The findings underscore the importance of considering body iron markers when assessing cardiovascular risk in the middle-aged general population. It may help in developing personalized diagnostic and managing approaches for unhealthy cardiovascular metabolic status.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.